A total of 429 g-ray-induced thymic lymphomas were obtained from F 1 and backcross mice between BALB/c and MSM strains, about a half of which carried a p53-de®cient allele. A genome-wide allelic loss analysis has revealed two loci exhibiting frequent allelic losses but no allelic preference, one is localized within a 2.9 cM region between D12Mit53 and D12Mit279 loci on chromosome 12, and the other is near the D16Mit122/D16Mit162 loci on chromosome 16. The frequency of allelic loss in the D12Mit279 region is 62% and does not dier in tumors between the presence and absence of the p53-de®cient allele. In contrast, the loss frequency of D16Mit122 is raised by the existence of p53-de®cient allele: 62% for p63(7/+) and 13% for p53(+/+), suggesting cooperative function of the two losses. The D12Mit279 and D16Mit122 regions probably harbor dierent types of tumor suppressor gene that play key roles in lymphoma development.
Introduction
Inactivation of tumor suppressor genes is frequently associated with allelic loss of a chromosomal region containing the normal allele, consistent with Knudson's hypothesis (Knudson, 1985) . Therefore, allelic loss or loss of heterozygosity (LOH) analysis is a standard method to locate the regions carrying tumor suppressor genes involved in neoplastic development and malignant progression (Weinberg, 1991; Levine, 1993) . Such studies have been performed for human and murine tumors and are recently facilitated by development of many microsatellite markers (Dietrich et al., 1996; Suda et al., 1994) . One of the genes showing frequent allelic loss and mutations is the p53 gene that is involved in cell-cycle checkpoints and responds to DNA damages induced by genotoxic agents such as gray radiation (Hollstein et al., 1991; Halevy et al., 1991; Greenblatt et al., 1994; Ootsuyama et al., 1994) . As for mouse thymic lymphomas induced by girradiation and chemical agents, however, the frequency of p53 loss is relatively low (Braithwaite et al., 1992; Saez et al., 1994) . This implies that other transformation-associated genes are involved in the initiation and/or progression of lymphomas. Indeed, several loci on chromosomes 2, 4, 11 and 12 have been mapped (Zhuang et al., 1996; Santos et al., 1996) but none of them are localized at the cM level except for the region named TLSR1 (thymic lymphoma suppressor region 1) on mouse chromosome 4 comprising the p16 gene (Santos et al., 1996) . This may be ascribed to the small number of analysed tumors (less than 50 tumors).
The aim of this study is the ®ne mapping of chromosomal regions exhibiting frequent allelic loss in g-ray-induced thymic lymphomas. We obtained a total of 429 lymphomas, using F 1 mice and N 2 backcross mice between BALB/c and MSM strains belonging to two dierent subspecies that showed frequent genetic variations (Hayashi et al., 1993; Suda et al., 1994) . In order to enhance lymphoma development, mice carrying a p53-de®cient allele were used, which are known to be susceptible to radiationinduced lymphomagenesis (Harvey et al., 1993; Lee and Bernstein, 1993; Lee et al., 1994) . A genome-wide allelic loss analysis has localized two loci exhibiting frequent allelic loss. One is present within approximately 3 cM region surrounding the D12Mit279 locus on chromosome 12, and the other is in the vicinity of D16Mit122 on chromosome 16. We have also demonstrated the contribution of p53 loss to allelic loss of the D16Mit122 locus but not to allelic loss of the D12Mit279 locus.
Results

Survey of regions showing frequent allelic loss
Allelic loss or loss of heterozygosity analysis was carried out for 20 lymphomas developed in F 1 mice together with respective normal brain tissues. Sixty-two microsatellite markers, whose loci were distributed throughout the genome, were used for this analysis. Results are summarized in Figure 1 (the typing patterns not shown but some examples in Figures 3 and 5). We identi®ed several loci showing considerably high frequencies of allelic loss, though four regions on chromosomes 3, 7, 11 and 15 could not be examined because of lack of heterozygosity in normal tissues (see Materials and methods). Among them, three markers of D11Mit71, D12Mit81 and D16Mit122 exhibited high frequencies, 40, 65 and 45%, respectively. We chose the two regions in the vicinity of the D12Mit181 and D16Mit122 loci for further analysis, but not the D11Mit71 locus because of its location near the p53 gene locus.
Localization of TLSR12a on chromosome 12
To map the region showing frequent allelic loss in the vicinity of the D12Mit181 locus relative to known mouse genes or markers, we performed a preliminary analysis for other 61 F 1 lymphomas using three markers, D12Mit6 (40 cM from the centromere), D12Mit181 (50 cM) and D12Mit8 (63 cM). It was found that their frequency of allelic loss was 33% (27/81), 65% (53/81) and 56% (45/81), respectively (see parentheses in Figure 1 ), suggesting that the region giving the highest loss frequency is located around the D12Mit181 locus.
Nine markers and seven markers in the vicinity of D12Mit181 were clustered in single loci in the MIT map, the two clusters being approximately 4 cM apart. Hence, we ®rst performed genetic typing of these 16 markers using 688 backcross mice. Their revised order was as follows: Centromere ± D12Mit100 ± 0.58 cM ± (D12Mit28, D12Mit29) ± 1.2cM ± (D12Mit50, D12-Mit261, D12Mit207) ± 0.58cM ± D12Mit132 ± 2.2cM ± (D12Mit53, D12Mit122) ± 2.9cM ± (D12Mit233, D12-Mit279, D12Mit181) ± 0.73cM ± D12Mit80 ± 0.58cM ± (D12Mit262, D12Mit79) ± 3.9cM ± D12Mit141. Using these markers covering 13 cM region, we analysed 348 lymphomas developed in the N 2 backcross mice. Since only lymphomas had developed in mice showing heterozygosity for marker loci were informative, 173 to 182 lymphomas depending on loci could be used for such analysis. Results are summarized in Figure 2a . The D12Mit279 locus exhibited the highest frequency of allelic loss. Since this region can be a candidate site harboring tumor suppressor gene for thymic lymphoma, we designate the locus as TLSR12a (thymic lymphoma suppressor region 12a).
There were 83 N 2 lymphoma samples heterozygous for all markers localized between D12Mit132 and D12Mit80. Among them, 16 lymphoma samples turned out to be useful to localize a commonly lost region. As for the F 1 lymphomas, ten samples were useful out of the 53 lymphomas showing allelic loss. The remaining 110 N 2 and F 1 lymphomas showed allelic losses in all marker loci. Figure 3 shows allelic loss patterns of six samples. Comparison of the extent of allelic loss indicated that the region between D12Mit53 and D12mit279/233 was the only site to be consistently lost in these lymphomas (Figure 4 ). This suggests that TLSR12a is located within the 2.9 cM region. In the deletion map, the D12Mit181 and D12Mit279/233 loci were clearly separated. The allelic loss of D12Mit279 did not exhibit allelic preference, 
TLSR16a region on chromosome 16
A similar analysis was carried out for the region showing frequent allelic loss on chromosome 16, designated as TLSR16a. Eighty-one F 1 lymphomas were subjected to allelic loss analysis using three markers, D16Mit122 (7 cM from the centromere), D16Mit1 (18 cM) and D16Mit4 (25 cM). The results revealed that the frequency of allelic loss was 47% (38/ 81), 40% (32/81) and 30% (24/81), respectively (see parentheses in Figure 1 ), suggesting that the region giving the highest loss frequency is located around the D16Mit122 locus. Then, we typed the backcross mice with 14 markers in the vicinity of D16Mit122. Their revised order was as follows: CentromereD16Mit181 ± 0.44cM ± (D16Mit80, D16Mit9, D16-mit160) ± 0.44 ± (D16Mit192, D16Mit122, D16-Mit131, D16Mit142, D16Mit72) ± 0.29cM ± D16Mit162 ± 0.29cM ± D16Mit161 ± 0.29cM ± D16Mit-183 ± 0.29cM ± D16Mit164 ± 3.6cM ± D16Mit74. Using those markers, allelic loss analysis was done for 175 ± 179 heterozygous lymphomas depending on loci that were obtained from the 348 N 2 lymphomas. The D16Mit162 locus exhibited the highest frequency of allelic loss (summarized in Figure 2b ).
The regions on chromosome 16 showing allelic losses tended to be larger than the regions on chromosome 12. Consequently, only six N 2 and four F 1 lymphomas were useful for localization. Four examples of allelic loss patterns are shown in Figure 5 . The other 102 lymphomas showed allelic losses in all marker loci within the region between D16Mit9/160 and D16Mit74. One sample, F71, showed a unique recombination pattern that only the D16Mit122 and D16Mit162 loci of the MSM chromosome remained in the lymphoma ( Figure 6 ). Avoiding this data, the results allowed us to localize a commonly lost region ( Figure 6 ). This suggests that the TLSR16a locus may be present within a 0.29 cM region between D16Mit122/72 and D16Mit62. No allelic preference was observed; the loss of the BALB/c and MSM alleles was 53/118 and 65/118, respectively.
Eects of p53 genotypes on allelic loss frequencies
The p53 genotype of the mice developing lymphoma was determined by PCR using two sets of primers (Tsukada et al., 1993; Ohashi et al., 1996) . One pair of primers detected the presence of normal p53 allele, and the other determined the existence of the disrupted p53 allele (see Materials and methods). The analysis of 81 F 1 mice showed that 54 lymphomas were derived from p53-heterozygous mice and 27 lymphomas were from p53-wild-type mice (patterns not shown). On the other hand, 128 N 2 C backcross mice exhibited that 77 lymphomas were derived from p53-heterozygous mice and 51 lymphomas were from p53-wild-type mice, while among the 220 N 2 M mice producing lymphomas, mice having the p53-de®cient allele were 160 and p53 wild-type mice were 60. The allelic loss frequencies of the D12Mit279 and D16Mit122 loci were separately calculated for lymphomas in F 1 (p537/+), F 1 (p53+/+), N 2 C(p537/+), N 2 C(p53+/+), N 2 M(p537/+) and N 2 M(p53+/+). As shown in Table 1 , the loss frequencies of D12Mit279 did not dier either in tumors among F 1 mice and the two kinds of backcrossed mice nor between the presence and absence of the p53-de®cient allele. In contrast, the allelic loss frequency of the D16Mit122 showed dierence. The loss frequencies were 19%, 9% and 11% in the p53-wild-type mice of F 1 , N 2 C and N 2 M, respectively. On the other hand, the frequencies in the p53 heterozygotes were as high as about 59%, 48% and 71%, respectively. This suggests an association between the presence of p53-de®cient allele in mice and allelic loss around the D16Mit122 locus in lymphoma.
We also examined the relationship between allelic losses at the TLSR12a and TLSR16a loci. Lymphomas consisted of four combinations of the presence or absence of allelic losses at the two loci. The number of lymphomas in each group was calculated. Thirty-®ve lymphomas did not show allelic loss either at the D12Mit279 locus or at the D16Mit122 locus. Sixtyseven lymphomas exhibited the loss only at the D12Mit279 locus and 27 did only at the D16Mit122 locus. Fifty-seven displayed allelic losses at both loci. The w 2 value was 0.098, indicating no relationship. Hence, allelic losses at the two loci occurred independently.
Using PCR with a set of primers that detected a variation in the promoter region between B6 (or CBA) and MSM, we examined whether or not the tumors developed in p53(7/+) mice retained the wild-type allele of p53. Representative results are shown in Figure  7 . DNA from normal tissue of a p53(7/+) N 2 M mouse exhibited two polymorphic bands, one was derived from the B6 (or CBA) p53 allele disrupted by the insertion of neo DNA and the other from the wild-type allele of MSM. Most lymphomas had lost the latter band. Such loss of the wild-type allele was observed in 137 out of the 160 lymphomas induced in p53(7/+) N 2 M mice, the loss frequency was 85.6%. A similar analysis was carried for 60 lymphomas induced in the p53(+/+) N 2 M mice. The allelic loss frequency was 11.7% (7/60).
Discussion
Two loci showing frequent allelic loss
The present study describes a genome-wide allelic loss analysis of 429 thymic lymphomas in total that were induced in F 1 and N 2 mice between BALB/c and MSM carrying a p53-de®cient allele. The BALB/c strain is susceptible to g-ray-induced lymphomagenesis (Okumoto et al., 1989 (Okumoto et al., , 1990 , whereas MSM is resistant. The resistance of MSM is con®rmed by observing no tumor formation within 300 days after exposure of 27 MSM mice to g-ray radiation (data not shown). Two loci showed frequent allelic losses. One, designated as TLSR12a, is located within the 2.9 cM region between D12Mit53 and D12Mit279/233 on chromosome 12, while the other, TLSR16a, is found in the vicinity D16Mit122/D16Mit162 on chromosome 16.
It has been reported that the distal region on chromosome 12 around the D12Mit263 locus shows a frequent allelic loss by analysis of 2', 3'-dideoxycytidine-and 1, 3-butadiene-induced mouse lymphomas (Zhuang et al., 1996) . The D12Mit263 locus is approximately 7 cM apart from the TLSR12a locus. Although the latter ®nding may indicate that the two regions exhibiting frequent allelic loss are distinct, further analysis is needed before de®nite conclusion is made because of a relatively small number (18 samples) of the chemically induced lymphomas analysed. An interval around the D12Mit279 locus on mouse chromosome 12 is syntenic to human chromosome 14q32-33. This region has been found to show frequent allelic loss in colorectal carcinomas (Young et al., 1993) , neuroblastomas (Suzuki et al., 1989) and invasive bladder cancer (Chang et al., 1995) . As for the mouse chromosome 16, frequent allelic loss was also found in the vicinity of the TLSR16a region by analysis of tumors developed in transgenic mice bearing simian virus 40 large antigen (Dietrich et al., 1994) . The region, named Loh-2, is present between D16Mit1 and D16Mit14 which is near but apart from the TLSR16a locus. We previously reported that the loss of a chromosome 16 in tumor cell clones derived from (C3H/B6) F 1 mice confers metastatic potential, suggesting that chromosome 16 harbors a metastasis suppressor gene (Mafune et al., 1994) . Although TLSR16a might be related with this activity, further analysis is necessary to elucidate their relationship.
Analysis of 47 g-ray-inducd lymphomas that are derived from F 1 mice between B6 and RF/J has revealed that the TLSR1 locus near the p16 gene on chromosome 4 shows a frequent allelic loss (45%) (Santos et al., 1996) . Allelic loss of such a region is also frequently observed in thymic lymphomas in F 1 mice between BALB/c and STS (Okumoto et al., unpublished) . In those tumors allelic preference in the chromosomal loss is observed, the RF/J and STS alleles are favored. On the other hand, allelic loss of this region was not frequently detected in our F 1 and N 2 mice between BALB/c and MSM. This dierence may be ascribed to the genetic background eect given by MSM or possibly to the MSM and BALB/c alleles in the TLSR1 locus belonging to the same type. Per cent of lymphomas showing allelic loss is shown for two types of F 1 mice: p53(7/+) and p53(+/+), and four dierent types of the backcross mice: N 2 C with or without the p53-de®cient allele and N 2 M with or without the p53-de®cient allele. The number in parenthesis indicates fraction of lymphomas giving allelic loss per lymphomas examined. The w 2 value for the D16Mit122 locus is 24 (P<0.0001), indicating that the presence of p53-de®cient allele is associated with the allelic loss of this locus B M KO 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Liver Lymphoma Figure 7 Loss of the wild-type allele of p53 in tumors from p53(7/+) heterozygous mice. Thirteen out of 14 lymphomas had lost the wild type MSM allele and only one sample retained the allele (sample 9). A vertical bar on the right indicates the position of heteroduplexes formed between complementary B6 (or CBA) and MSM fragments. See text for details Eects of p53 on tumor incidence and allelic losses
Tumor incidence was higher in the mice carrying a p53-de®cient allele than in the p53-wild-type mice (see the Result section and Table 1 ), indicating that the presence of one p53-de®cient allele in cells contributes to the development of thymic lymphoma. Examination of the remaining wild-type allele of the p53 gene in lymphomas revealed a high frequency of the loss (85.6%) which resulted in complete impairment of the p53 function. Thus, we infer that the eect of the p53-de®cient allele on tumor development is attributed to the loss of p53 function in tumors.
There is no dierence in the frequency of allelic loss of TLSR12a between lymphomas induced in the p53(7/+) and p53(+/+) mice, suggesting that p53 de®ciency does not aect generation of allelic loss of TLSR12a (Table 1 ). This might be an unexpected result, because it is thought that p53 suppresses tumor formation in part by preventing the accumulation of DNA damage resulting from irradiation. One of the p53 roles is to ensure that, in response to genotoxic damage, cells arrest in G 1 and attempt to repair their DNA before it is replicated (Kuerbitz et al., 1992; Hartwell and Kastan, 1994; Sherr, 1996) . Accordingly, p53 loss would confer an elevated rate of the loss of TLSR12a in lymphomas. The lack of in¯uence of p53 loss in the lymphomas may be accounted by the limitation of p53 loss that the p53 loss can aect tumor development or tumor phenotype only in late stages of carcinogenesis (Greenblatt et al., 1994; Sherr, 1996) .
In addition to arrest in G 1 , p53 can induce apoptosis in a variety of diverse cell types including mouse thymocytes (Lowe et al., 1993) . This role implies that the loss of p53 function may indirectly contribute to tumorigenesis by permitting the propagation of premalignant lymphomas initiated by irradiation. Indeed, it has been reported that p53 mutation does not aect initiation events in tumorigenesis of skin cancers and choroid plexus tumors (Kemp et al., 1993; Morgenbesser et al., 1994; Symonds et al., 1994) . This idea is consistent with the observation that p53 mutations frequently occur in late stages of human cancers and are often associated with aggressive tumors (Hollstein et al., 1991; Greenblatt et al., 1994) . It is therefore possible that the TLSR12a gene negatively regulates cell growth at an initiation stage and the p53 gene functions at a late stage. The loss of both genes would greatly contribute to tumor development in dierent fashions.
In contrast, allelic loss of TLSR16a in lymphomas is associated with the absence of p53-de®cient allele (Table 1) . It is unlikely that frequent mutation occurs in this region selectively for the tumors with p53 loss. Rather, this apparent elevation of the loss frequency probably re¯ects selection of cells with the loss in both p53 and TLSR16a during lymphomagenesis. Because of the role of p53 in the DNA damage checkpoint control, this selection may be due to either escape from apoptosis or cooperation of the p53 and TLSR16a losses to bring about malignant transformation.
Interestingly, the Scid gene functioning in DNA repair has been mapped in the vicinity of TLSR16a (Miller et al., 1995; Hamatani et al., 1996) . Mice lacking this gene show enhanced susceptibility to the induction of thymic lymphomas by x-irradiation (Lieberman et al., 1992) . It is possible that loss of the gene increases unrepaired double-strand breaks in lymphomas and subsequently the breaks-containing cells are normally eliminated through apoptotic pathway controlled by the p53 function. The cells lacking p53 would be allowed to propagate such cells and some of the cells may give rise to lymphoma. This could be the case of selection due to apoptosis mentioned above. Examination of the Scid gene in the lymphomas revealed, however, that allelic loss was less frequent than that in the D16Mit122 locus, suggesting that the gene is not involved. Another candidate may be the Rapop1 (radiation-induced apoptosis 1) gene that controls susceptibility to radiation-induced apoptosis (Mori et al., 1995) . It is located at a proximal region of chromosome 16 in the vicinity of TLSR16a but their relation is totally unknown at present.
Another possibility of the cooperative function is suggested by the gene-de®cient mouse experiment, the Rb(+/7) and p53(7/7) mice develop a wide range of tumors at earlier ages than mice that are either Rb(+/ 7) or p53(7/7) alone, indicating their cooperative activity (Morgenbesser et al., 1994; Symonds et al., 1994; Williams et al., 1994) . A similar cooperation is found between p53 and Wnt-1 (Donehower et al., 1995) . These cooperative property is consistent with ®ndings that many types of human tumor exhibit mutations in both of the two genes and that tumors of some cell types require inactivation of both genes . It is possible, therefore, that TLSR16a comprises a tumor suppressor gene of the Rb gene type whose loss functions cooperatively with p53 loss.
Materials and methods
Lymphoma samples
Lymphomas obtained from F 1 mouse were produced for allelic loss analysis but lymphomas from backcross mice were made initially to investigate tumor susceptibility. The details of lymphoma induction and incidence will be published elsehwere. In brief, the parental p53-de®cient mouse used was originally produced by introduction of a neo-gene fragment into the p53 gene locus in the ES cells that had been derived from F 1 mouse between C57BL/ 6(B6) and CBA strains (Tsukada et al., 1993) . The mice were maintained by back-crossing to B6 mice. We have developed a partially congenic MSM mouse carrying a p53-de®cient allele by back-crossing of this p53-de®cient mouse to MSM mice ®ve times. MSM is an inbred strain derived from Japanese wild mice, Mus m. molossinus (Bonhomme and Guenet, 1989) . The male mouse (N 5 generation) was then crossed to MSM females to produce mice (N 6 generation) used for the present experiment. The parental mice were mated with BALB/c, and F 1 progeny carrying the p53 mutant allele were selected with neo-gene primers (Tsukada et al., 1993) . Some of the F 1 mice were backcrossed to BALB/c and approximately 200 N 2 backcross mice (N 2 C) were obtained, while about 600 N 2 backcross mice (N 2 M) were produced by crossing the F 1 to MSM. The F 1 mice and the two types of N 2 mice, about a half of which carried a p53-de®cient allele, were subjected to fractionated doses of g-ray irradiation, 2.5 Gy four times at a week interval, when they were at age of 4 weeks. Thymic lymphoma development was diagnosed by the inspection of labored breathing. Finally, 94, 154 and 347 tumors were obtained from 112 F 1 mice, 176 N 2 C mice and 512 N 2 M mice, respectively. Among those tumors, 81 128 and 220 were thymic lymphoma, respectively.
Genotyping the N 5 male mouse with 70 polymorphic markers distributed throughout the genome (the markers shown in Figure 1 ) demonstrated that most chromosomal regions were homozygous except markers on four chromosomes (shown by vertical open bars in Figure 1) . (1) The region around the p53 gene locus, which retained DNA of the C57BL/6 or CBA strain, was an approximately 55 cM distance from a centromeric site between D11Mit71 and D11Mit106 to a telomeric site between D11Jpk3 and D11Mit12; (2) the region on chromosome 3: from a centromeric site between D3Mit6 and D3Jpk2 to a telomeric site between D3Mit10 and D3Mit17; (3) the region on chromosome 7: from the centromere to a site between D7Mit18 and D7Mit17; (4) the region on chromosome 15: from a site between D15Mit11 and D15Mit9 to a site between D15Mit3 and D15Mit15.
PCR analysis
Genomic DNA was extracted from lymphomas and brain by standard protocols, and subjected to polymerase chain reaction (PCR). PCR was carried out in a 10 ± 20 ml volume under conditions as described (Mafune et al., 1994; Ohashi et al., 1996) . The reaction was processed through 30 ± 35 cycles of ampli®cation consisting of 1 min at 948C, 1 min at 558C, and 1 min at 728C, with the last elongation step lengthened to 10 min. Products were separated by electrophoresis on 4% NuSieve-agarose gel or on 8% polyacrylamide gel.
Primers
Microsatellite markers were synthesized according to sequences reported (Dietrich et al., 1996; Suda et al., 1994) . Primers for analysis of the p53 promoter were 5'-GCTGGATAGGAAAGAGCACAG and 5'-TGAGATG-TTGCCCTCAGCAG, which were located 7478 bp* ± 289 bp 5' to the transcription start site. Sequence analysis showed an addition of 9 bp at 7399 bp in the MSM allele relative to the BALB/c and B6 alleles.
p53 genotyping was carried as described previously (Ohashi et al., 1996) . One primer (F1-53) was located in exon 1 of the p53 gene, a second primer (R1-53) was in a region 5' to exon 3, and the remaining one (F2-neo) was in the neo gene inserted. Their sequences were, 5'-AATTGA-CAAGTTATGCATCCATACAGTACA, 5'-ACTCCTCAA-CATCCTGGGGCAGCAACAGAT, and 5'-GAACCTG-CGTGCAATCCATCTTGTTCAATG, respectively. F1-53 and R1-53 ampli®ed a region of the endogenous p53 gene to produce a fragment of 500 bp. F2-neo and R1-53 gave a 800 bp fragment comprising a part of the neo and p53 genes. Therefore, the 500 bp band and the 800 bp band indicate the presence of normal allele and mutant allele, respectively.
